YL-109

SKU: orb1306970

Description

YL-109 is a novel small molecule compound with demonstrated anticancer activity. It effectively suppresses the proliferation and invasive capacity of breast cancer cells in both in vitro and in vivo models, making it a valuable research tool for oncology and metastasis studies.

Research Area

Immunology & Inflammation, Metabolism Research

Key Properties

• CAS Number: 36341-25-0
• MW: 257.31
• Purity: 98.00% (May vary between batches)
• Formula: C₁₄H₁₁NO₂S
• SMILES: COc1cc(ccc1O)-c1nc2ccccc2s1
• Target: AhR|||Aryl Hydrocarbon Receptor
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2.5 mg/mL (9.72 mM);DMSO:55 mg/mL (213.75 mM);H2O:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

• Target IC50:
  Proliferation (MCF-7 cells):85.7 nM

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

CHIP, breast, AhR, antitumor, ArylHydrocarbonReceptor, aryl, Aryl Hydrocarbon Receptor, cancer, carboxyl, Hsp70-interacting, hydrocarbon,AhR, Inhibitor, inhibit, invasiveness, YL 109, YL109, YL-109, protein, terminus

Compound Identifiers

PubChem CID

3155228